About Spero Therapeutics
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Spero Therapeutics
|Address||StreetAddress: 675 Massachusetts Ave Fl 14, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2139, AddressCountry: United States|
|Number Of Employees||35|
|Ticker Symbol||NASDAQ: SPRO|
New York City, US
17 Sep 2023
Page: 1 Desktop | Laptop Devices
https://www.sperotherapeutics.com/Spero Therapeutics | Developing MDR Bacterial Infection ...
Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for ...
People Also Ask
https://twitter.com/Spero_Tx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorSpero Therapeutics (@Spero_Tx) · Twitter
https://finance.yahoo.com › quote › SPROSpero Therapeutics, Inc. (SPRO) Stock Price, News, Quote ...
Find the latest Spero Therapeutics, Inc. (SPRO) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.linkedin.com › company › spero-therape...Spero Therapeutics
Oct 22, 2022 — We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for ...
https://www.cnbc.com › quotes › SPROSPRO: Spero Therapeutics Inc - Stock Price, Quote and ...
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, and commercializing treatments ...
https://www.crunchbase.com › organization › spero-th...Spero Therapeutics - Crunchbase Company Profile & ...
Spero Therapeutics develops therapeutics for treatment of gram-negative infections. ... Spero Therapeutics raised to date? Spero Therapeutics has raised. $443.6M.
https://atlasventure.com › company › spero-therapeuticsSpero Therapeutics
Spero Therapeutics is developing novel therapies to treat highly resistant bacterial infections. The company is in partnership with Roche to develop its ...
https://www.pfizer.com › news › press-release-detailSpero Therapeutics Announces $40 Million Equity ...
Jun 30, 2021 — Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel ...
Spero therapeutics stock price
spero therapeutics address
spero therapeutics news